KCP
LLY icon

Kera Capital Partners’s Eli Lilly LLY Stock Holding History

Kera Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
899
-34
-4% -$34.7K 0.1% 114
2026
Q1 		$858K Buy
933
+172
+23% +$174K 0.11% 113
2025
Q4 		$789K Buy
761
+199
+35% +$190K 0.1% 126
2025
Q3 		$429K Buy
562
+251
+81% +$187K 0.06% 185
2025
Q2 		$242K Buy
311
+11
+4% +$8.55K 0.05% 265
2025
Q1 		$248K Buy
300
+1
+0.3% +$832 0.07% 142
2024
Q4 		$231K Buy
+299
New +$248K 0.07% 116

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kera Capital Partners's LLY Position: Q2 2026 in Review

Kera Capital Partners reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $34.7K and leaving 899 shares worth $1.08M. The position accounts for 0.1% of the portfolio, ranked #114.

Kera Capital Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kera Capital Partners held 899 shares of Eli Lilly worth $1.08M as of Q2 2026.
  • Kera Capital Partners sold 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 0.1% of Kera Capital Partners's portfolio in Q2 2026, its #114 holding.
  • Kera Capital Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.